Skip to content

Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01897818
Enrollment
20
Registered
2013-07-12
Start date
2013-07-31
Completion date
Unknown
Last updated
2013-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Brief summary

ALS is a severe progressive neurodegenerative disease characterized by degeneration motor neurons leading to death in 3 to 5 years. Gradually in time, the patient deprived of all motor skills as well as the possibility of communication written and oral developing a state close Locked In Syndrome (LIS). The main objective is to establish the feasibility of brain-computer interface using the pathological condition, with dependent disabled subjects as a means of communication.

Interventions

DEVICEcommunication system P300 Speller

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>= 18 * have a diagnosis of ALS suspected, possible, probable with EMG * be able to follow the study process and to comply with the schedule of visits upon entry into the study * understand the purpose of the study * expressing P300 wave in the conditions of the study

Exclusion criteria

* have a mental illness or clinical dementia defined clinically significant may hinder the patient's ability to follow the procedures of the study * have a significant history of photosensitive epilepsy * have a history of allergy to the gel used for the electrodes * Major protected by law (guardianship, curators) * have uncorrectable visual disorders * not being able to maintain a sitting position and focus on a computer screen for more than 30 min.

Design outcomes

Primary

MeasureTime frame
the full achievement of copy spelling and free spelling tests session 114 days after inclusion
the full achievement of copy spelling and free spelling tests session 228 days after inclusion

Countries

France

Contacts

Primary ContactClaude DESNUELLE, Pr
desnuelle.c@chu-nice.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026